These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 2327760
1. Purification and characterization of inducible beta-lactamases in Aeromonas spp. Iaconis JP, Sanders CC. Antimicrob Agents Chemother; 1990 Jan; 34(1):44-51. PubMed ID: 2327760 [Abstract] [Full Text] [Related]
3. Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems. Bakken JS, Sanders CC, Clark RB, Hori M. Antimicrob Agents Chemother; 1988 Sep; 32(9):1314-9. PubMed ID: 3264129 [Abstract] [Full Text] [Related]
4. Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. Shannon K, King A, Phillips I. J Antimicrob Chemother; 1986 Jan; 17(1):45-50. PubMed ID: 3485091 [Abstract] [Full Text] [Related]
5. [Phenotypes of beta-lactam resistance in the genus Aeromonas]. Fosse T, Giraud-Morin C, Madinier I. Pathol Biol (Paris); 2003 Jul; 51(5):290-6. PubMed ID: 14567197 [Abstract] [Full Text] [Related]
6. Group 1 beta-lactamases of Aeromonas caviae and their resistance to beta-lactam antibiotics. Lupiola-Gómez PA, González-Lama Z, Tejedor-Junco MT, González-Martín M, Martín-Barrasa JL. Can J Microbiol; 2003 Mar; 49(3):207-15. PubMed ID: 12795407 [Abstract] [Full Text] [Related]
7. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme. Rasmussen BA, Keeney D, Yang Y, Bush K. Antimicrob Agents Chemother; 1994 Sep; 38(9):2078-85. PubMed ID: 7811022 [Abstract] [Full Text] [Related]
8. A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible beta-lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity. Walsh TR, Payne DJ, MacGowan AP, Bennett PM. J Antimicrob Chemother; 1995 Feb; 35(2):271-9. PubMed ID: 7759391 [Abstract] [Full Text] [Related]
9. beta-Lactam resistance of motile Aeromonas isolates from clinical and environmental sources. Morita K, Watanabe N, Kurata S, Kanamori M. Antimicrob Agents Chemother; 1994 Feb; 38(2):353-5. PubMed ID: 8192463 [Abstract] [Full Text] [Related]
10. Partial characterization of Nocardia farcinica beta-lactamases. Steingrube VA, Wallace RJ, Brown BA, Zhang Y, Steele LC, Young G, Nash DR. Antimicrob Agents Chemother; 1993 Sep; 37(9):1850-5. PubMed ID: 8239595 [Abstract] [Full Text] [Related]
11. Three beta-lactamases isolated from Aeromonas salmonicida, including a carbapenemase not detectable by conventional methods. Hayes MV, Thomson CJ, Amyes SG. Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):805-11. PubMed ID: 7889949 [Abstract] [Full Text] [Related]
12. Distribution and expression of beta-lactamase genes among Aeromonas spp. Walsh TR, Stunt RA, Nabi JA, MacGowan AP, Bennett PM. J Antimicrob Chemother; 1997 Aug; 40(2):171-8. PubMed ID: 9301981 [Abstract] [Full Text] [Related]
13. Susceptibility of Rhodobacter sphaeroides to beta-lactam antibiotics: isolation and characterization of a periplasmic beta-lactamase (cephalosporinase). Baumann M, Simon H, Schneider KH, Danneel HJ, Küster U, Giffhorn F. J Bacteriol; 1989 Jan; 171(1):308-13. PubMed ID: 2783689 [Abstract] [Full Text] [Related]
14. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH. Antimicrob Agents Chemother; 1993 May; 37(5):939-46. PubMed ID: 8517720 [Abstract] [Full Text] [Related]
15. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yoshimura F, Kato N. Antimicrob Agents Chemother; 1994 Jan; 38(1):71-8. PubMed ID: 8141584 [Abstract] [Full Text] [Related]
16. In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens. Miller MA, Finan M, Yousuf M. J Antimicrob Chemother; 1983 Apr; 11(4):311-8. PubMed ID: 6343337 [Abstract] [Full Text] [Related]
17. Properties of cephalosporinase from Proteus morganii. Toda M, Inoue M, Mitsuhashi S. J Antibiot (Tokyo); 1981 Nov; 34(11):1469-75. PubMed ID: 6976340 [Abstract] [Full Text] [Related]
18. Purification and characterization of a new beta-lactamase from Clostridium butyricum. Kesado T, Lindqvist L, Hedberg M, Tunér K, Nord CE. Antimicrob Agents Chemother; 1989 Aug; 33(8):1302-7. PubMed ID: 2802556 [Abstract] [Full Text] [Related]
19. Inducible beta-lactamases in clinical isolates of non-aeruginosa Pseudomonas. Ravaoarinoro M, Toma E, Fallara A. APMIS; 1992 Jun; 100(6):523-30. PubMed ID: 1610551 [Abstract] [Full Text] [Related]
20. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase. Bush K, Flamm RK, Ohringer S, Singer SB, Summerill R, Bonner DP. Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992 [Abstract] [Full Text] [Related] Page: [Next] [New Search]